The latest closing stock price for EFFECTOR Therapeutics as of July 02, 2024 is 0.18.
An investor who bought $1,000 worth of EFFECTOR Therapeutics stock at the IPO in 2021 would have $-982 today, roughly -1 times their original investment - a -73.75% compound annual growth rate over 3 years.
The all-time high EFFECTOR Therapeutics stock closing price was 27.17 on September 08, 2021.
The EFFECTOR Therapeutics 52-week high stock price is 17.75, which is 9761.1% above the current share price.
The EFFECTOR Therapeutics 52-week low stock price is 0.17, which is 5.6% below the current share price.
The average EFFECTOR Therapeutics stock price for the last 52 weeks is 4.24.
An investor who bought $1,000 worth of EFFECTOR Therapeutics stock at the IPO in 2021 would have $-982 today, roughly -1 times their original investment - a -73.75% compound annual growth rate over 3 years.
The all-time high EFFECTOR Therapeutics stock closing price was 27.17 on September 08, 2021.
The EFFECTOR Therapeutics 52-week high stock price is 17.75, which is 9761.1% above the current share price.
The EFFECTOR Therapeutics 52-week low stock price is 0.17, which is 5.6% below the current share price.
The average EFFECTOR Therapeutics stock price for the last 52 weeks is 4.24.